Supplemental material
Journal of Dermatological Treatment
Volume 33, 2022 - Issue 3
Articles
Efficacy, tolerability, patient usability, and satisfaction with a 2 mL pre-filled syringe containing secukinumab 300 mg in patients with moderate to severe plaque psoriasis: results from the phase 3 randomized, double-blind, placebo-controlled ALLURE study
Bardur Sigurgeirssona Department of Dermatology, Faculty of Medicine, University of Iceland, Reykjavik, IcelandCorrespondence[email protected]
https://orcid.org/0000-0002-9733-9742View further author information
https://orcid.org/0000-0002-9733-9742View further author information, , Chih-Ho Hongc Dr. Chih-Ho Hong Medical Inc., Surrey, Canada;d Probity Medical Research, Waterloo, Canada;e Department of Dermatology and Skin Science, University of British Columbia, Vancouver, Canadahttps://orcid.org/0000-0001-9963-8319View further author information
https://orcid.org/0000-0001-9963-8319View further author information, Isaak Effendyf Department of Dermatology, Municipal Hospital of Bielefeld, Bielefeld, Germanyhttps://orcid.org/0000-0002-8293-6616View further author information
https://orcid.org/0000-0002-8293-6616View further author information, , , , , , , & show allReprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related Research Data
Linking provided by
